ARN2966

APP expression modulator CAS# 102212-26-0

ARN2966

Catalog No. BCC8074----Order now to get a substantial discount!

Product Name & Size Price Stock
ARN2966: 5mg $161 In Stock
ARN2966: 10mg Please Inquire In Stock
ARN2966: 20mg Please Inquire Please Inquire
ARN2966: 50mg Please Inquire Please Inquire
ARN2966: 100mg Please Inquire Please Inquire
ARN2966: 200mg Please Inquire Please Inquire
ARN2966: 500mg Please Inquire Please Inquire
ARN2966: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of ARN2966

Number of papers citing our products

Chemical structure

ARN2966

3D structure

Chemical Properties of ARN2966

Cas No. 102212-26-0 SDF Download SDF
PubChem ID 14936865 Appearance Powder
Formula C12H12N2O M.Wt 200.24
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : ≥ 43.4 mg/mL (216.74 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name 2-(pyridin-2-ylmethylamino)phenol
SMILES C1=CC=C(C(=C1)NCC2=CC=CC=N2)O
Standard InChIKey GXJRVWZNMZGWAQ-UHFFFAOYSA-N
Standard InChI InChI=1S/C12H12N2O/c15-12-7-2-1-6-11(12)14-9-10-5-3-4-8-13-10/h1-8,14-15H,9H2
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of ARN2966

DescriptionARN2966 is a potent post-transcriptional modulator of APP expression; reduces expression of APP with resultant lower production of Aβ. IC50 value: Target: Aβ This potent post-transcriptional modulation of APP expression differs from other mechanisms such as inhibition of secretases. Secretase inhibitors have been pursued as disease modifying strategies by a number of pharmaceutical firms but they have encountered numerous setbacks during clinical development. ARN2966 is non toxic, orally absorbable, blood-brain-barrier penetrable, and effective in vitro and in vivo.

References:
[1]. http://arianeurosciences.com/science.html

ARN2966 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

ARN2966 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of ARN2966

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 4.994 mL 24.97 mL 49.9401 mL 99.8801 mL 124.8502 mL
5 mM 0.9988 mL 4.994 mL 9.988 mL 19.976 mL 24.97 mL
10 mM 0.4994 mL 2.497 mL 4.994 mL 9.988 mL 12.485 mL
50 mM 0.0999 mL 0.4994 mL 0.9988 mL 1.9976 mL 2.497 mL
100 mM 0.0499 mL 0.2497 mL 0.4994 mL 0.9988 mL 1.2485 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on ARN2966

ARN2966 is a potent post-transcriptional modulator of amyloid precursor protein (APP) expression in transfected CHO cells. The CHO cell can produce APP.[1]

APP is the amyloid precursor protein of Alzheimer’s disease. Alzheimer’s disease is a progressive dementia with the symptoms of neuronal degeneration, synaptic loss, and the deposition of amyloid fibrils in the brain. Ab protein is the major constituent of the amyloid . Then the Ab protein derives from the amyloid precursor protein (APP). It has been proved that APP can stimulate neurite outgrowth in vitro. [2]

The modulation of App expression of the ARN2966 functions as a post-transcriptional modulation,which is different from other mechanisms such as inhibition of secretases. ARN2966 showed dose dependant inhibition of Aß40 and Aß42 productions in APP751SW transfected CHO cells (IC50<1 mM for Aß40), along with lowering the level of APP and C83, and C99 peptides, while the level of APP mRNA was unaffected..[1]

There has been AD transgenic mice model proved ARN2966’s efficacy and tolerability in vivo. Through the treatment of ARN2966, the memory of mice has been improved and A load in the brain has been reduced.

References:
[1] Ayodeji Asuni ,Xu Kevin , etal. , An APP translation modulator ARN2966 reduces BETA-AMYLOID deposition and prevents memory deficits in ALZHEIMER'S DISEASE transgenic mice. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, July 2012Volume 8, Issue 4, Supplement, Page S744 ;
[2]Williamson TG1, Mok SS, Henry A, etal.  , Secreted glypican binds to the amyloid precursor protein of Alzheimer's disease (APP) and inhibits APP-induced neurite outgrowth. J Biol Chem. 1996 Dec 6;271(49):31215-21.

Featured Products
New Products
 

Description

ARN2966 is a potent post-transcriptional modulator of APP expression; reduces expression of APP with resultant lower production of Aβ.

Keywords:

ARN2966,102212-26-0,Natural Products,Amyloid β, buy ARN2966 , ARN2966 supplier , purchase ARN2966 , ARN2966 cost , ARN2966 manufacturer , order ARN2966 , high purity ARN2966

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: